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Summary 
Alkyl gallates are anticipated for their use as antibacterial and antiviral agents. Although their 
pharmacological activities depend on their alkyl chain length, no mechanism has yet been clarified. 
As described herein, we investigated the membrane binding properties of a series of alkyl gallates 
using fluorescence measurement to elucidate their different pharmacological activities. Membrane 
binding of the alkyl gallates increased concomitantly with increasing alkyl chain length, except for 
cetyl gallate and stearyl gallate. Dynamic light scattering revealed that alkyl gallates with a long 
alkyl chain are prone to self-association in the solution. Membrane binding abilities of the alkyl 
gallates are correlated with antibacterial and antivirus activities, as described in previous reports. 
The partition constants of the alkyl gallates to lipid membranes depend on the membrane 
components and the membrane phase. Self-association and lipid binding of the alkyl gallates might 
be primary biophysical factors associated with their pharmacological activities. 
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1. Introduction 
Gallate is a general term used to describe salts and esters of gallic acid with the galloyl group. 
Some gallate compounds, typically catechin and proanthocyanidin gallates, have been developed for 
pharmacological applications [1–7]. Among them, alkyl gallates have recently been regarded as 
affecting microbial cell viability [8–18], virus activity [19–25], and human leukemia cell 
proliferation [26]. The alkyl gallates’ pharmacological activity increases concomitantly with their 
alkyl chain length. Therefore their activity has been attributed to their surfactant-like effects, which 
can induce lipid membrane disruption and membrane protein inactivation [11–13]. In fact, alkyl 
gallates have both a hydrophilic galloyl group and hydrophobic alkyl chain. More hydrophobic 
species with longer alkyl chains, e.g. dodecyl gallate [8,9] and stearyl gallate [10,11], do not 
function as antibacterial agents, suggesting an unknown factor that determines the cutoff point for 
activity [9]. 
Fluorescence spectra have been used often for analyses of interactions of various aromatic 
compounds with lipid membranes because fluorescence spectra depend greatly on the solution 
environment [27]. For example, membrane binding of peptides and low-molecular-weight 
compounds has been observed through changes in fluorescence intensity [28–34]. Furthermore, 
fluorescence analyses present the advantage of being quantitative. For that reason, the 
thermodynamic parameters of the interactions, such as partition constants, can be determined. The 
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membrane binding affinity for catechin derivatives has been measured to investigate their 
pharmacological activities [35]. 
Although partition constants of alkyl gallates with lipid membranes might be related to their 
pharmacological activity, partition constants have not been examined aside from qualitative 
observations [36]. This study revealed that the partition constant depends on the alkyl chain length of 
gallate. The constant of the alkyl gallates increased concomitantly with increasing hydrophobicity, 
except for longer alkyl chain species such as cetyl and stearyl gallates. These two alkyl gallates are 
exceptional probably because of their self-association detected by dynamic light scattering 
measurements. Moreover, the membrane-binding of alkyl gallates was found to be correlated with 
the pharmacological activity of a series of alkyl gallates. Consequently, our findings are useful for 
understanding not only the physicochemical properties of alkyl gallates, but also for elucidating their 
pharmacological activity. 
 
 6 
 
2. Materials and methods 
Chemicals: All alkyl gallates were obtained from Tokyo Kasei Kogyo Co. Ltd. (Tokyo, Japan). 
Dioleoylphosphatidylcholine (DOPC), dipalmitoylphosphatidylcholine (DPPC), 
dioleoylphosphatidylglycerol (DOPG), and cholesterol were obtained from NOF Corp. (Tokyo, 
Japan) along with sodium dihydrogen phosphate (Nacalai Tesque Inc., Kyoto, Japan) and ethanol 
(Kanto Chemical Co. Inc., Tokyo, Japan). All compounds were of the highest commercially 
available grade. 
 
2.1 Solubility measurement of alkyl gallates: The respective solubilities of alkyl gallates in 10 mM 
phosphate buffer (pH 7.4) were measured as follows [38]. An appropriate amount of alkyl gallate 
powder was transferred into a test tube, to which 1.5 ml of 10 mM phosphate buffer (pH 7.4) was 
added. The suspension was heated at 40 °C for 1 h with frequent vortexing for complete dissolution 
of alkyl gallate powders. The solution was then incubated at 25 °C for 3 days with frequent 
vortexing. Subsequently, the suspension was centrifuged at 25 °C and 16,000 × g for 20 min to 
obtain a supernatant saturated with the alkyl gallates. After appropriate dilution of the supernatant 
with water, the supernatant absorbance was determined spectrophotometrically at 271 nm using a 
UV–VIS spectrophotometer (ND-1000; NanoDrop Technologies, Inc.., Wilmington, DE, USA). The 
absorbance value was converted to the concentration based on the standard curve determined for 
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methyl gallate. Solubility was determined in triplicate, from which the averages and standard errors 
were obtained. 
 
2.2 Observation of self-association of alkyl gallates: To verify the self-association of the alkyl 
gallates, dynamic light scattering (DLS) measurements of them at 3 µM were conducted at 25 °C 
using a light-scattering spectrometer (DLS-7000; Ostuka Electronics Co., Ltd. Osaka, Japan) 
equipped with an argon ion laser at scattering angles of 90° [46]. Samples that did not pass the 
instrument’s internal quality criteria were omitted. 
 
2.3 Preparation of lipid membranes: Large unilamellar vesicles (LUV) composed of DOPC, DOPG, 
DPPC, and cholesterol (Chol) were used as model lipid membranes, prepared using the extrusion 
method with 200 nm pore size polycarbonate membranes. The appropriate amounts of 5 mM lipids 
were mixed in chloroform. Subsequently, the solvent was removed completely in a vacuum 
desiccator connected to a rotary vacuum pump for 12 h. To this dry lipid film, 1 ml of 10 mM 
phosphate buffer (pH 7.4) was added; then the 1.5 mM lipid suspension was vortexed for several 
seconds above the phase-transition temperature (25 °C for DOPC and DOPG, and 40 °C for DPPC). 
Subsequently, the solutions were extruded through 200-nm-pore-size polycarbonate membranes 
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(Avanti Mini-Extruder; Avanti Polar Lipids, Inc., Alabaster, AL) at a temperature higher than the 
phase-transition temperature. 
 
2.4 Fluorescence analysis of the binding of alkyl gallates to phospholipid membranes: Fluorescence 
spectra of 3 µM alkyl gallate in 10 µM lipids with 10 mM phosphate buffer (pH 7.4) were recorded 
at 25 °C. Only for C8–18 were they presolubilized in ethanol before mixing with the lipid solution to 
determine the alkyl gallate concentration. Thereby, the final component of the solution was 3 µM 
alkyl gallate, 10 µM lipids, 0.6% ethanol, and 10 mM phosphate buffer (pH 7.4), where the residual 
ethanol did not affect their fluorescence spectra. Finally, the fluorescence intensity of each reference 
solution without the alkyl gallate was subtracted from the intensity of the sample solutions. The 
determined intensities were averages of triplicate experiments. Thereby, the average and standard 
error were obtained. These spectra were measured using a spectrofluorometer (FP6500; Jasco Corp., 
Tokyo, Japan). The emission fluorescence spectra were recorded for 200–500 nm, using the 
excitation wavelength of 271 nm. 
 
2.5 Measurement of the partition constant of alkyl gallates to the membranes: To determine the 
partition constant of the alkyl gallates (C8–C16) to the membranes, the changes in fluorescence 
intensity of the alkyl gallate on the membrane-binding were monitored using a spectrofluorometer. 
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The prepared sample solutions contained various concentrations of the lipids comprising DOPC, 
DPPC/DOPC or DPPC/Chol, 60 nM alkyl gallates, 0.6% ethanol, and 10 mM phosphate buffer (pH 
7.4). The fluorescence intensity of each reference solution without the alkyl gallates was subtracted 
from the intensity of the sample solutions. The determined intensities were averages of triplicate 
experiments: the average and standard error were obtained. 
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3. Results 
3.1 Solubility and hydrodynamic radius of alkyl gallates: The alkyl gallates used for this study are 
shown in Scheme 1, where they are termed C1–C18 according to the carbon number of the alkyl 
chain. The solubility of the alkyl gallates in 10 mM phosphate buffer solution was measured for 
physicochemical characterization of the alkyl gallates. As shown in Table 1, the solubility of C2 is 
higher than that of C1, which is consistent with our previous study [37, 38]. The solubility of C12 is 
lower than that of C16, which is not surprising when considering the dynamic light scattering 
measurements as follows. Results show that C16 and C18 tend to self-associate in the solution (Fig. 
1). The solutions of C16 and C18 respectively exhibit a unimodal size distribution with mean 
diameters of 84.6 ± 4.6 nm and 130.6 ± 17.6 nm. In contrast, C8 and C12 were not detected using 
the same apparatus. It can be concluded that the self-association of C16 and C18 increases their 
apparent solubilities. 
 
3.2 Binding of alkyl gallates to phospholipid membranes: Binding of the alkyl gallates to the 
membranes was observed through the change of fluorescent intensities of their aromatic moiety. 
Figure 2 presents fluorescence spectra of C4 in the presence or absence of DOPG or DOPC. As 
expected, the fluorescence spectrum of C4 differed in the presence of positively charged DOPG or 
amphoteric DOPC. Accordingly, results suggest that the binding of C4 to the membranes is mainly 
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attributable to the hydrophobic interaction between DOPC and the alkyl chains of the alkyl gallates. 
Similar data were obtained for C1, C2, and C3 (Fig. S1). To support the suggestion presented above, 
we investigated the dependence of the alkyl chain length of the binding to DOPC. Ratios of the 
fluorescence intensity in the presence of DOPC to that in the absence of DOPC increased with 
elongation of the alkyl chain length (Fig. 3A). The ratios for C1–C12 increased with the alkyl chain 
length (Fig. 3, see Fig. S2 for their spectral data). The changes in fluorescence intensities of their 
aromatic moiety are caused by the polarity of the solution environment [31]. In contrast, the 
fluorescence intensity of C16, despite its longer alkyl chain, was weaker than that of C12. 
Additionally, the intensity of C18 did not change according to the presence of the lipid membrane. 
 
3.3 Estimation of the partition constant of alkyl gallates to phospholipid membranes: Partition 
constants of the alkyl gallates to the membranes were estimated from the binding isotherms as 
follows. Figure 4A shows representative data for the peak intensity of the fluorescence spectra of C8 
in various concentrations of DOPC, as normalized by the maximum value. The normalized intensity 
in Fig. 4A increased by the addition of DOPC and subsequently reached a plateau at which all C8 
molecules bind to the membrane. Here, a two-state transition was presumed: binding or non-binding 
states of the alkyl gallates to the membrane. Additionally, it was assumed that the alkyl gallates bind 
to both the internal and external monolayer. Consequently, the equilibrium concentration of the alkyl 
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gallate in the bulk solutions, as denoted by Ceq, was obtained as [28] 
 
Ceq = CT - CM = CT (1- FN),      (1) 
 
where CT and CM respectively denote the total concentration of the alkyl gallate in solution and its 
concentration in the lipid membranes. Therein, FN denotes the normalized fluorescence intensity 
corresponding to the vertical axis in Fig. 4A. The molar ratio of the alkyl gallate molecules in the 
membranes to total lipid molecules, denoted by Xb, is given as 
 
Xb= CT FN / CL ,      (2) 
 
where CL is the lipid concentration in solution. Finally, because the ratio of the concentration of the 
alkyl gallate to that of the lipid membrane in the solution is low, Xb can be expressed as [29] 
 
Xb= Kint Ceq ,       (3) 
 
where Kint is the intrinsic partition constant of the alkyl gallate to the lipid membrane. According to 
these analyses, Xb and Ceq are actually mutually proportional (Fig. 4B). These calculations are 
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applicable to the other alkyl gallates, except for C1–C4 and C18: because of their weak binding 
affinity to the membrane, their binding curves were not obtained. The partition constants for C8, 
C12 and C16 are presented in Table 2; the partition constants for C12 and C16 were of the same 
order and an order of magnitude higher than that for C8. These results reflect that the partition 
constant for C16 might be affected by self-association of C16, as described above (Fig. 1). 
 
3.4 Effect of membrane components on the binding of alkyl gallate to phospholipid membranes: The 
membrane liquid–solid phase differs according to its components [39]. They can be expected to 
affect the binding affinity of the alkyl gallates. Figure 5A exhibits the partition constants for C8, C12, 
and C16 to the lipid membranes composed of various ratios of DPPC/DOPC. The partition constants 
for these alkyl gallates increased concomitantly with the increasing ratio of DOPC to DPPC; the 
value for DOPC was twice that for DPPC. Figure 5B shows alteration of the partition constants for 
these alkyl gallates to the membranes containing cholesterol. The partition constants for C8 and C12 
decreased concomitantly with increasing concentration of cholesterol, although that for C16 was 
maintained. 
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4. Discussion 
Alkyl gallates are anticipated for use as antibacterial and antiviral agents because various studies 
have already shown their pharmacological activity in vitro [8–25]. Therefore, their biophysical 
properties should be clarified in advance of their application. Nevertheless, quantitative studies such 
as thermodynamic studies of the binding interaction of the alkyl gallates to lipid membranes have 
not been reported. Additionally, it has not been established why highly hydrophobic alkyl gallates 
with a longer alkyl chain did not function as antibacterial agents [8–11]. Regarding the binding 
interaction of the alkyl gallates to lipid membranes, only qualitative observations have been 
performed [36]. In this study, we quantitatively examined the binding ability of alkyl gallates with 
different alkyl chain lengths to various lipid membranes. It is worth mentioning that this is the first 
report of a partition constant between the alkyl gallates and phospholipid membrane. Ratios of 
fluorescence intensity of C1–C12 have increased concomitantly with increasing alkyl chain length 
(Fig. 3). The ratios for C1–C12 increased with the logarithm of the octanol–water partition 
coefficient (log P) of the alkyl gallates. Therefore, it was suggested that the membrane-binding 
ability of C1–C12 depends on their hydrophobicity derived from the alkyl chain. However, for more 
hydrophobic species with a longer alkyl chain (C16, C18), the intensity decreased. Here, recall that 
DLS measurements for C8–C18 indicated self-association of C16 and C18, even at concentrations 
below solubility (Fig. 1, Table 1). Assuming that the self-associated forms have no ability to interact 
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with the lipid membrane, the observed reduction of the membrane-binding ability for C16 and C18 
can be ascribed to the promotion of self-association with increasing alkyl chain length. The result, 
that C16 but not C18 interacted with the membranes (Fig. 3B), presents the possibility that the 
self-association state of C16 is an equilibrium, with the soluble monomeric state binding to the lipid 
membranes. 
Reportedly, antibacterial and antiviral activities of the alkyl gallates decrease as their alkyl chain 
length increases beyond a certain length [8–11], indicating a cutoff point for the activity of the alkyl 
gallates [9]. Reduction of the activity will be reasonable according to our observations. The 
reduction can be attributed to the promotion of the self-association with increasing alkyl chain length. 
In other words, such self-associated species can not interact with the bacterial cell membranes or 
envelopes of viruses. Therefore, their activities would be reduced. Consequently, the 
pharmacological activity of the alkyl gallates can be expected to be associated closely with their 
physicochemical properties such as hydrophobicity and the monomeric solubility. To assess the 
relation between the physicochemical properties and the pharmacological activity, we investigated 
the correlation between the membrane binding ability and pharmacological activity (Table 3), where 
the binding ability was evaluated using the ratios of the fluorescence intensity of the alkyl gallates 
(F/F0). Most correlation coefficients were positive and greater than 0.7. Therefore, the 
membrane-binding ability of the alkyl gallates will probably account for the results obtained for the 
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pharmacological activity. It is noteworthy that the correlation coefficients for Trichophyton rubrum 
and Microsporum gypseum were lower than the others. Consequently, the pharmacological activity 
of the alkyl gallates might be partly accounted for by other functions including disruption of lipid 
membranes, inactivation of membrane proteins and their downstream activities. 
The alkyl gallates‘ interaction with cholesterol and with phospholipids also constitutes important 
information. Lipid membranes composed of DPPC, DOPC, and cholesterol are often used as cell 
membrane models with phase changes depending on the composition ratio [39–44]. The results 
presented in Fig. 5 indicate that the alkyl gallates are more stable in the liquid phase of DPPC/DOPC 
than in the solid phase, although they are less stable in the liquid phase of DPPC/Chol than in the 
solid phase. Consequently, the stability of alkyl gallates in lipid membranes depends substantially on 
the membrane components rather than the membrane phase. The direct interaction of the alkyl 
gallates with the lipid components might be related with various pharmacological effects toward 
bacterial cells [12,14] and viruses [19,21]. 
Finally, the stability of the alkyl gallate in aqueous solution depends on the co-existing solutes, as 
shown in our previous study [37,38]. Alteration of the stability in the solution by the solutes can 
affect the partition constants and thereby affect their activity toward bacterial cells and viruses. Such 
effects of solutes are potentially applicable to prevent self-association and to enhance their 
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bioavailability as drugs and food additives. We are carrying out systematic investigations of the 
solute effects to elucidate their potential benefits. 
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Table 1. Solubility of the alkyl gallates in 10 mM phosphate buffer (pH 7.4) at 25 °C 
Gallate  Solubility (M) 
Metyl (C1) 6.46 ± 0.11×10-2 
Ethyl (C2) 8.19 ± 0.05×10-2 
Propyl (C3) 1.92 ± 0.01×10-2 
Butyl (C4) 1.21 ± 0.02×10-2 
Octyl (C8) 5.7 ± 0.6×10-4 
Dodecyl (C12) 6.4 ± 0.8×10-5 
Cetyl (C16) 9.1 ± 0.7×10-5 
Stearyl (C18) 3.9 ± 0.7×10-5 
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Table 2. Intrinsic partition constant (Kint) of octyl (C8), dodecyl (C12) and cetyl (C16) gallates to 
the lipid membrane of DOPC 
 
 
 
 
 
Gallate  Kint (1/M) 
Octyl (C8) 1.5 ± 0.1×105 
Dodecyl (C12) 8.2 ± 0.7×105 
Cetyl (C16) 8.4 ± 0.6×105 
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Table 3. Calculated correlation coefficients between ratios of the fluorescence intensity (F/F0) and 
the pharmacological activity of the alkyl gallates against bacteria and viruses 
Targets r[a] Ref. 
Propionibacterium acnes 0.949 [13] 
Brevibacterium ammoniagenes 0.892 [13] 
Staphylococcus aureus (MRSA) 0.892 [13] 
Micrococcus luteus 0.824 [13] 
Bacillus subtilis 0.824 [13] 
Streptococcus mutans 0.593 [13] 
Trichophyton mentagrophytes 0.409 [16] 
Trichophyton rubrum 0.135 [16] 
Microsporum gypseum 0.129 [16] 
Targets r[b] Ref 
Herpes simplex virus type-1 0.745 [19] 
Lenzites betulina 0.785 [14] 
Gloeophyllum trabeum 0.729 [14] 
Chaetomium globosum 0.716 [14] 
Trametes versicolor 0.683 [14] 
[a]: Correlation coefficients between ratios of the fluorescence intensity (F/F0) determined in this 
paper and antibacterial activities of the alkyl gallates (log(1/MIC)), where MIC is the minimum 
inhibitory concentration, as described in reports of previous studies [13,16]. [b]: Correlation 
coefficients between F/F0 and the yield of antiviral effects [19] and antifungal fractions [14]. The 
calculated correlation coefficients are the Pearson product-moment correlation coefficients [45].  
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Scheme 1. Chemical structures of the alkyl gallates. 
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Figure 1. DLS measurements for 3 µM cetyl gallate (C16) (solid line) and stearyl gallate (C18) 
(broken line) in water. 
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Figure 2. Fluorescence spectra of 3 µM butyl gallate (C4) in the presence and absence of 10 µM 
DOPC or DOPG: no lipid, solid line; DOPC, broken line; DOPG, dotted line. The excitation 
wavelength of the fluorescence spectra is 271 nm. 
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Figure 3. Ratios of the fluorescence intensity of the respective 3 µM alkyl gallates (A) C1–C4 and 
(B) C4–C18 in the presence of 10 µM DOPC to those in the buffer solution. 
 33 
 
 
Figure 4. (A) Normalized fluorescent intensity of 60 nM octyl gallate (C8) at 350 nm in various 
concentrations of DOPC, normalized by the maximum value. (B) Binding isotherms of octyl gallate 
(C8) to the lipid membrane of DOPC at 25 °C. 
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Figure 5. Binding constants (Kint) of 60 nM octyl gallate (C8) (closed circles, left axes), dodecyl 
gallate (C12) (open circles, right axes) and cetyl gallate (C16) (open squares, right axes) in the 
presence of DPPC/DOPC (A) and DPPC/Chol (B). 
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Supporting Information 
Figure S1. Fluorescence spectra of 3 µM metyl gallate (C1) (A), etyl gallate (C2) (B) and propyl 
gallate (C3) (C) in the presence or absence of 10 µM DOPC or DOPG: no lipid, solid line; DOPC, 
broken line; DOPG, dotted line. The excitation wavelength of the fluorescence spectra is 271 nm. 
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Figure S2. Fluorescence spectra of 3 µM octyl gallate (C8) (A), dodecyl gallate (C12) (B), cetyl 
gallate (C16) (C), and stearyl gallate (C18) (D) in the absence (solid lines) and presence (broken 
lines) of 10 µM DOPC. The excitation wavelength of the fluorescence spectra is 271 nm. 
